IMNPQ Insider Trading Activity and SEC Form 4 Filings
IMNPQ insider trading summary
No open-market insider purchases or sales of Immune Pharmaceuticals Inc (IMNPQ) have been reported on SEC Form 4 in the past 12 months.
Latest IMNPQ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 3, 2020 | Anthony S. Fiorino | Director | Sell | $263 (75,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.